ORACLE: Observation of ResiduAl Cancer with Liquid Biopsy Evaluation
Details
Age
Adult
Eligibility
- treated with curative intent - planning to undergo regular follow up and monitoring for cancer recurrence per standard of care at the enrolling site patients must have either: - Esophageal or gastroesophageal junction carcinoma (stage II-III) or - Gastric adenocarcinoma (stage II-III) or - Surgically resected pancreatic adenocarcinoma
Type of Study
Diagnostic
Locations
University of Colorado Hospital
Principal Investigator
Robert Lentz, MD
Study ID
Protocol Number: 22-0526
More information available at ClinicalTrials.gov: NCT05059444
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers